Extra Space Storage heads into its May 14 Q1 earnings call with an unusual tailwind: short sellers have spent the past month quietly walking away.
Short interest has fallen sharply — down 16% over the past month to just under 2% of the free float. That's a meaningful retreat from the early-April peak, when shorts held closer to 5 million shares. The trend has been consistent rather than spiky, with the position shrinking almost every week through late April and into May. A reading below 2% of float is modest by any measure. This is not a heavily contested stock, and the direction of travel makes it less so by the day.
The borrow market reinforces that picture. Availability is extremely loose — well above 1,000% relative to short interest — meaning there is abundant supply for anyone wanting to build a position against the stock. Cost to borrow has ticked up 8% over the week to 0.57%, but at that level it remains essentially free money to short. The ORTEX short score of 32.8 places EXR firmly in the lower half of the short-pressure spectrum, and the score has drifted lower over the past two weeks. Options positioning tells a somewhat different story. The put/call ratio has climbed to 0.77, running well above its 20-day average of 0.65 and sitting 1.6 standard deviations above the mean — the highest level in several months. Investors are buying more downside protection ahead of earnings than they have been recently, even as dedicated short sellers reduce their stakes.
The Street's view is cautiously constructive but has been softening at the margins. Truist trimmed its target this week from $158 to $150 while keeping a Hold rating — a signal that near-term expectations are being dialled back even among neutral voices. Wells Fargo, which carries an Overweight, also cut its target modestly in mid-April, to $148 from $150. Barclays remains the most bullish outlier with a $170 target and an Overweight rating, while JPMorgan sits at Neutral with a $144 target. The consensus price target of $151.90 implies roughly 9% upside from Tuesday's close of $139.79. EV/EBITDA has edged up to 18.3x over the week, modest expansion that reflects the stock's 4.4% gain over the past month even as forward estimates haven't moved decisively. EPS momentum scores in the 22nd percentile on a 90-day basis, underscoring that analyst estimate revisions have been tilted lower — consistent with the bear case around margin compression and a same-store revenue growth outlook of between -0.5% and +1.5% for 2026.
The institutional register is stable and passive-heavy, with Vanguard holding 16.3% and BlackRock 10.7%. One notable recent addition: Capital Research added 2.5 million shares in Q1, making it the fifth-largest holder at 6.4% of shares outstanding. That's an active manager taking a meaningful fresh position, and it adds a constructive counterpoint to the cautious sell-side tone. Insider activity has been one-directional, with the CEO selling $1.07 million of stock in mid-March and the CFO and Chief Accounting Officer adding small sells on April 1. The net 90-day insider position is a sale of roughly $5 million in value — routine for a large REIT, but not a signal of internal bullishness.
The closest peers have had a mixed week. PSA gained 0.6% on the week while CUBE slipped 1.1%, leaving EXR's -0.9% weekly move roughly in line with the sector. SAFE stands out with an 8.4% weekly drop, suggesting some idiosyncratic stress in parts of the REIT complex that hasn't spread to the storage names.
With earnings on May 14, the focal point shifts to occupancy trends and the peak leasing season outlook. Occupancy has already slipped 40 basis points year-on-year to 92.5%, and investors will be watching whether management's increased marketing spend is translating into move-in rate support — or simply eating into margins that were already under pressure from expense growth running at 2–3.5%.
See the live data behind this article on ORTEX.
Open EXR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
